UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): January 11, 2023
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||
(Address of principal executive offices)
Registrant's telephone number, including area code: (404 ) 671-4000
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 11, 2023, the Board of Directors (the “Board”) of Sharecare, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, increased the size of the Board from 9 to 10 members and appointed Brent Layton to fill the vacancy so created, both effective January 11, 2023. Mr. Layton was appointed to serve as a Class II director and will stand for re-election at the 2023 Annual Meeting of Stockholders. Mr. Layton will serve on the Board’s Audit Committee.
The Board has determined that Mr. Layton meets the independence standards adopted by the Board in compliance with The Nasdaq Stock Market listing rules (the “Nasdaq Rules”) and Item 407(a) of Regulation S-K. In addition, the Board has determined that Mr. Layton satisfies the independence requirements applicable to the Board’s Audit Committee under the Nasdaq Rules and the rules and regulations of the Securities and Exchange Commission.
Mr. Layton has (i) no arrangements or understandings with any other person pursuant to which he was appointed to as a director, and (ii) no family relationship with any director or executive officer of the Company or any person nominated or chosen by the Company to become a director or executive officer.
Mr. Layton currently serves as Senior Advisor to the CEO of Centene Corporation (“Centene”), and he previously served as President and Chief Operating Officer of Centene. Centene is a customer of the Company and the Company received approximately $875,000 from Centene in 2022. As a result of such customer relationship, Mr. Layton may be deemed to have a direct or indirect material interest with respect to the Company’s transactions with Centene as contemplated by Item 404(a) of Regulation S-K. As of the date of this Current Report on Form 8-K, Mr. Layton holds no direct or indirect beneficial ownership in the Company’s stock or rights to acquire the Company’s stock.
Mr. Layton will be compensated in accordance with the Company’s previously-disclosed compensation program for its non-employee directors as described in the Company’s most recent proxy statement. Mr. Layton will also enter into a standard indemnification agreement with the Company in the form previously approved by the Board, which is filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on July 8, 2021 and is incorporated by reference herein.
The Company issued a press release on January 11, 2023 announcing the appointment of Brent Layton to the Company’s Board. A copy of the press release is attached as Exhibit 99.1 to this report and incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit | Description | |||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SHARECARE, INC. | |||||
Dated: | |||||
By: /s/ Carrie Ratliff | |||||
Name: Carrie Ratliff | |||||
Title: Chief Legal Officer | |||||
Sharecare appoints Brent Layton to board of directors
ATLANTA – Jan. 11, 2023 – Sharecare, Inc. (Nasdaq: SHCR) (“Sharecare”), the digital health company that helps people manage all their health in one place, has appointed healthcare industry veteran and retiring Centene Corporation executive Brent Layton to its board of directors and Audit Committee, effective today.
Mr. Layton has more than 30 years of experience with increasing responsibility in the healthcare and public policy sectors, with extensive expertise in creating, scaling, and operating business in a highly regulated environment. Currently serving as senior advisor to the CEO at Centene Corporation, Mr. Layton plays a pivotal role in developing and expanding key strategic partnerships for the company and driving its business development strategy.
"Brent’s experience in managed care and government-sponsored plan architecture and delivery will be invaluable as we continue our mission to help people live happier, healthier lives, no matter where they are on their well-being journey," said Jeff Arnold, co-founder, chairman, and CEO of Sharecare. “As we approach our third year as a publicly traded company, Brent’s leadership and counsel will help us better serve our members as well as our health plan and government partners, and, ultimately, benefit our shareholders.”
Previously, Mr. Layton served as president and chief operating officer for Centene Corporation where he oversaw the company's healthcare offerings, including 31 State Medicaid Health plans, the nation's largest Exchange provider, Ambetter, and the WellCare brand of Medicare products, and was a member of the Office of the CEO. Since joining Centene in 2006, he has overseen the development and implementation of new health plans in more than 25 states, provided strategic guidance to state governments to help them develop effective Medicaid solutions, and developed new business contracting with providers and health systems where he led the company's effort in value-based purchasing.
“I’m excited to work with Sharecare as they realize their vision to optimize and improve the healthcare experience for all stakeholders, including and especially those who need better access to care,” said Layton. “It is a privilege to join the team at such a pivotal juncture in which government continues to look at ways to expand digital health solutions to advance health equity and improve outcomes.”
About Sharecare
Sharecare is the leading digital health company that helps people – no matter where they are in their health journey – unify and manage all their health in one place. Our comprehensive and data-driven virtual health platform is designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. Driven by our philosophy that we are all together better, at Sharecare, we are committed to supporting each individual through the lens of their personal health and making high-quality care more accessible and affordable for everyone. To learn more, visit www.sharecare.com.
Media Relations:
Jen Martin Hall
jen@sharecare.com
Investor Relations:
Bob East, Westwicke
SharecareIR@westwicke.com